PharmAthene Interest Expense:
0.1157M for Dec. 31, 2012PharmAthene Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.1157M |
| Sept. 30, 2012 | 0.1125M |
| June 30, 2012 | 0.1114M |
| March 31, 2012 | 0.003M |
| Dec. 31, 2011 | 0.014M |
| Sept. 30, 2011 | 0.0099M |
| June 30, 2011 | 0.0152M |
| March 31, 2011 | 0.0154M |
| Dec. 31, 2010 | 3.121M |
| Sept. 30, 2010 | 0.946M |
| June 30, 2010 | 0.9215M |
| March 31, 2010 | 0.9482M |
| Dec. 31, 2009 | 0.8879M |
| Sept. 30, 2009 | 0.7489M |
| June 30, 2009 | 0.5984M |
| March 31, 2009 | 0.6021M |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
PIP Interest Expense Benchmarks
| Companies | |
|---|---|
| Emergent BioSolutions | 0.011M |
| BioTime | 0.00 |
| Savient Pharmaceuticals | 6.93M |
PIP Interest Expense Rankings
| Overall |
62nd percentile 2996 of 8005 |
| Sector |
45th percentile 374 of 686 in Healthcare |
| Industry |
39th percentile 151 of 248 in Biotechnology |
PIP Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 3.121M | Dec 2010 |
| Average | 0.4827M |
